These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18522159)

  • 1. [Use of molecular genetic analysis in selecting antitumor therapy].
    Imianitov EN; Moiseenko VM
    Vopr Onkol; 2008; 54(2):121-32. PubMed ID: 18522159
    [No Abstract]   [Full Text] [Related]  

  • 2. Efforts aimed at reducing noise, data overload in microarrays.
    Tuma RS
    J Natl Cancer Inst; 2005 Aug; 97(16):1173-5. PubMed ID: 16106018
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer pharmacogenetics.
    Marsh S
    Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cells: a step toward the cure.
    Boman BM; Wicha MS
    J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
    [No Abstract]   [Full Text] [Related]  

  • 5. The HER-2/neu story: from oncogene through prognostic marker to therapeutic strategy determinant and monoclonal therapy.
    Mehigan BJ; Kerin MJ
    Eur J Surg Oncol; 1999 Apr; 25(2):111-2. PubMed ID: 10218450
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted therapy and pharmacogenomic programs.
    Iqbal S; Lenz HJ
    Cancer; 2003 Apr; 97(8 Suppl):2076-82. PubMed ID: 12673699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular genetic tumor markers and their analysis for diagnosis and therapy of cancer patients].
    Ianov IuK; Novik AA; Belokhvostov AS
    Klin Med (Mosk); 1999; 77(11):4-9. PubMed ID: 10635622
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of topoisomerase IIalpha and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients.
    Oakman C; Moretti E; Galardi F; Santarpia L; Di Leo A
    Cancer Treat Rev; 2009 Dec; 35(8):662-7. PubMed ID: 19758759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone receptor, grade, human epidermal growth factor receptor 2, and topoisomerase II as predictors of response to chemotherapy.
    Mehta RS
    J Clin Oncol; 2008 May; 26(15):2596; author reply 2596-7. PubMed ID: 18487578
    [No Abstract]   [Full Text] [Related]  

  • 10. [A glycolytic marker test for individualizing the selection of chemical compounds for antitumor activity].
    Piruzian LA; Mikhaĭlovskiĭ EM
    Izv Akad Nauk SSSR Biol; 1992; (1):111-22. PubMed ID: 1583204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
    Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
    Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Versipelostatin: unfolding an unsweetened death.
    Sausville EA
    J Natl Cancer Inst; 2004 Sep; 96(17):1266-7. PubMed ID: 15339959
    [No Abstract]   [Full Text] [Related]  

  • 13. [Individualized anticancer therapies: which regulatory guidelines?].
    Bedairia N; Marty M
    Bull Cancer; 2008 Oct; 95(10):985-8. PubMed ID: 19004730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Locus HS.633957 expression in human gastrointestinal tract and tumors].
    Polev DE; Krukovskaia LL; Kozlov AP
    Vopr Onkol; 2011; 57(1):48-9. PubMed ID: 21598707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular markers having a prognostic or therapeutic value in cancer].
    Brousset P
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S69-70. PubMed ID: 18984307
    [No Abstract]   [Full Text] [Related]  

  • 16. [Signal transduction and its targeting from the cancer molecular genetic platform: applications and perspectives in pulmonary pathology].
    Merlio JP
    Ann Pathol; 2011 Nov; 31(5 Suppl):S40-2. PubMed ID: 22054456
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzymology of cancer cells (first of two parts).
    Weber G
    N Engl J Med; 1977 Mar; 296(9):486-92. PubMed ID: 319362
    [No Abstract]   [Full Text] [Related]  

  • 18. Enabling personalized cancer medicine through analysis of gene-expression patterns.
    van't Veer LJ; Bernards R
    Nature; 2008 Apr; 452(7187):564-70. PubMed ID: 18385730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tackling transcription factors: challenges in antitumor therapy.
    Grivas PD; Kiaris H; Papavassiliou AG
    Trends Mol Med; 2011 Oct; 17(10):537-8. PubMed ID: 21775208
    [No Abstract]   [Full Text] [Related]  

  • 20. ERBB2 in pediatric cancer: innocent until proven guilty.
    Gilbertson RJ
    Oncologist; 2005 Aug; 10(7):508-17. PubMed ID: 16079318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.